BIO RAD LABORATORIES INC CLASS A (BIO)
NYSE • Healthcare
Last close at July 21, 2026 at 20:00 UTC
Fundamentals Charts
About BIO RAD LABORATORIES INC CLASS A
Bio-Rad Laboratories, Inc. develops and sells life-science and clinical diagnostics products on the NYSE under BIO, operating in healthcare as a maker of laboratory and diagnostic systems. Across its two businesses, the company generated $2.6 billion of revenue in FY2025.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Get premium market insights delivered directly to your inbox.
Today's Snapshot
BIO ended the session -0.07% below yesterday's close of 301.90. End-of-day, the peer group was modestly in the green at 0.63%, providing a small boost to sentiment. Into the bell, BIO was moving toward an earnings checkpoint, now 9 days out on 30 July.
Trading Volume
Above 10d avg 277.6K
295.4K
vs S&P 500 Today
Underperforming Market
-0.97%
52-Week Position
Mid-range
61.1%
Updated: July 21, 2026 at 20:41 UTC